Suzhou, China

Qianghua Jiang

This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Pengxu Pharmatech Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qianghua Jiang. Retrieved from https://idiyas.com/inventor/qianghua-jiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qianghua Jiang: Innovator in Pharmaceutical Processes

Introduction

Qianghua Jiang is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for producing elagolix. His work is characterized by a focus on scalable production methods that enhance the efficiency of pharmaceutical manufacturing.

Latest Patents

Qianghua Jiang holds 1 patent related to his innovative processes. His patent, titled "Processes to produce elagolix," outlines a scalable method for the synthesis of elagolix and its salts, as well as the production of intermediate compounds. This invention is crucial for improving the accessibility and affordability of this important medication.

Career Highlights

Jiang is currently employed at Suzhou Pengxu Pharmatech Co., Ltd., where he continues to advance his research and development efforts. His expertise in pharmaceutical processes has positioned him as a valuable asset to his company and the industry at large.

Collaborations

Throughout his career, Qianghua Jiang has collaborated with talented professionals, including Pixu Li and Peng Wang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Qianghua Jiang's contributions to pharmaceutical processes exemplify the impact of innovative thinking in the field. His work not only advances scientific knowledge but also enhances the production of essential medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…